Helping patients suffering from neurological and psychiatric disorders by developing a pipeline of psychedelic compounds into licensed pharmaceutical medicines
$306—459m (Dealroom.co estimates Aug 2021.)
Beckley England (HQ)
RELATED LANDSCAPES AND LISTS
Not yet verified
Recent News about Beckley PsytechEdit
Tech stackLearn more about the technologies and tools that this company uses.